Arterial vimentin is a transglutaminase substrate: A link between vasomotor activity and remodeling?

Journal of Vascular Research

Volumn 44, Issue 5, 2007, Pages 339-344

  Gupta, Madhu ^a   Greenberg, Charles S ^b   Eckman, Delrae M ^a   Sane, David C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cross linking; Factor XIII; Inward remodeling; Transglutaminase; Vimentin

Indexed keywords

ALBUMIN; AMINE; AVIDIN; BLOOD CLOTTING FACTOR 8A; CALCIUM; DIMER; GLUTAMINE; MONOMER; PEROXIDASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; STREPTAVIDIN; TRANSFERRIN; VIMENTIN;

ADRENERGIC SYSTEM; AFFINITY LABELING; AMINO ACID SEQUENCE; ARTICLE; CAROTID ENDARTERECTOMY; ENZYME SUBSTRATE; HUMAN; HUMAN TISSUE; MOTOR ACTIVITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; TISSUE HOMOGENATE;

AMINES; AMINO ACID SEQUENCE; BIOTIN; BIOTINYLATION; CALCIUM; CAROTID ARTERIES; CAROTID STENOSIS; DIMERIZATION; ENDARTERECTOMY, CAROTID; FACTOR XIIIA; HEMORHEOLOGY; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; SEQUENCE ALIGNMENT; SERUM ALBUMIN; SUBSTRATE SPECIFICITY; TRANSFERRIN; TRANSGLUTAMINASES; VASODILATION; VIMENTIN;

EID: 34548159251     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000102277     Document Type: Article

References (34)

1. Greenberg CS, Birckbichler PJ, Rice RH: Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 1991;5:3071-3077.
2. Sane DC, Kontos JL, Greenberg CS: Roles of transglutaminases in cardiac and vascular diseases. Front Biosci 2007;12:2530-2545.
3. Langille BL, Dajnowiec D: Cross-linking vasomotor tone and vascular remodeling: a novel function for tissue transglutaminase? Circ Res 2005;96:9-11.
4. Bakker EN, Buus CL, Spaan JA, Perree J, Ganga A, Rolf TM, Sorop O, Bramsen LH, Mulvany MJ, VanBavel E: Small artery remodeling depends on tissue-type transglutaminase. Circ Res 2005;96:119-126.
5. Bakker EN, Pistea A, Spaan JAE, Rolf T, de Vries CJ, van Rooijen N, Candi E, VanBavel E: Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase. Circ Res 2006;99:86-92.
6. Haroon ZA, Wannenburg T, Gupta M, Greenberg CS, Wallin R, Sane DC: Localization of tissue transglutaminase in human carotid and coronary artery atherosclerosis: implications for plaque stability and progression. Lab Invest 2001;81:83-93.
7. Sumi Y, Inoue N, Azumi H, Seno T, Okuda M, Hirata K, Kawashima S, Hayashi Y, Itoh H, Yokoyama M: Expression of tissue transglutaminase and elafin in human coronary artery: implication for plaque instability. Atherosclerosis 2002;160:31-39.
8. Mosher DF: Cross-linking of fibronectin to collagenous proteins. Mol Cell Biochem 1984;58:63-68.
9. Kinsella MG, Wight TN: Formation of high molecular weight dermatan sulfate proteoglycan in bovine aortic endothelial cell cultures: evidence for transglutaminase-catalyzed cross-linking to fibronectin. J Biol Chem 1990;265:17891-17898.
10. Borth W, Chang V, Bishop P, Harpel PC: Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase. J Biol Chem 1991;266:18149-18153.
11. MacGillivray RT, Mendez E, Sinha SK, Sutton MR, Lineback-Zins J, Brew K: The complete amino acid sequence of human serum transferrin. Proc Natl Acad Sci USA 1982;79:2504-2508.
12. Meloun B, Moravek L, Kostka V: Complete amino acid sequence of human serum albumin. FEBS Lett 1975;58:134-137.
13. HonoréB, Madsen P, Basse B, Andersen A, Walbum E, Celis JE, Leffers H: Nucleotide sequence of cDNA covering the complete coding part of the human vimentin gene. Nucleic Acids Res 1990;18:6692.
14. Ikura K, Kita K, Fujita I, Hashimoto H, Kawabata N: Identification of amine acceptor protein substrates of transglutaminase in liver extracts: use of 5-(biotinamido)-pentylamine as a probe. Arch Biochem Biophys 1998;356:280-286.
15. Lee KN, Maxwell MD, Patterson MK Jr, Birckbichler PJ, Conway E: Identification of transglutaminase substrates in HT29 colon cancer cells: use of 5-(biotinamido)-pentylamine as a transglutaminase-specific probe. Biochim Biophys Acta 1992;1136:12-16.
16. Fuchs E, Weber K: Intermediate filaments: structure, dynamics, function and disease. Ann Rev Biochem 1994;63:345-382.
17. Clément S, Velasco PT, Murthy SNP, Wilson JH, Lukas TJ, Goldman RD, Lorand L: The intermediate filament protein, vimentin, in the lens is a target for cross-linking by transglutaminase. J Biol Chem 1998;273:7604-7609.
18. Candi E, Oddi S, Terrinoni A, Paradisi A, Ranalli M, Finazzi-Agro A, Melino G: Transglutaminase cross-links loricrin, involucrin and small proline-rich proteins in vitro. J Biol Chem 2001;276:35014-35023.
19. Shin DM, Jeon JH, Kim CW, Cho SY, Kwon JC, Lee HJ, Choi KH, Park SC, Kim IG: Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis. J Biol Chem 2004;279:15032-15039.
20. Trejo-Skalli AV, Velasco PT, Murthy SN, Lorand L, Goldman RD: Association of a transglutaminase-related antigen with intermediate filaments. Proc Natl Acad Sci USA 1995:92:8940-8944.
21. Bennett MR, Macdonald K, Chan S-W, Boyle JJ, Weissberg PL: Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence and apoptosis in human VSMC from atherosclerotic plaques. Circ Res 1998;82:704-712.
22. Bennett MR, Evan GI, Schwartz SM: Apoptosis of human vascular smooth muscle cells derived from atherosclerotic plaque to p53-mediated apoptosis. Circ Res 1997;81:591-599.
23. Fesus L: Transglutaminase-catalyzed protein cross-linking in the molecular program of apoptosis and its relationship to neuronal processes. Cell Mol Neurobiol 1998;18:683-694.
24. Verderio E, Nicholas B, Gross S, Griffin M: Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment and cell death. Exp Cell Res 1998;239:119-138.
25. Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MH: Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 1992;339:1566-1570.
26. Atinou A, Collins A: Molecular cloning and expression of 56-58 KD antigen associated with transplant coronary artery disease. Biochem Biophys Res Commun 1997;2336:716-718.
27. Thung SN, Wang D-F, Fasy TM, Hood A, Gerber MA: Hepatitis B surface antigen binds to human serum albumin cross-linked by transglutaminase. Hepatology 1989;9:726-730.
28. Buxman MM: The role of enzymatic coupling of drugs to proteins in induction of drug specific antibodies. J Invest Dermatol 1979;73:250-255.
29. Terzi F, Henrion D, Colucci-Guyon E, Federici P, Babinet C, Levy BI, Braind P, Friedlander G: Reduction of renal mass is lethal in mice lacking vimentin. J Clin Invest 1997;100:1520-1528.
30. Henrion D, Terzi F, Matrougui K, Duriez M, Boulanger CM, Colucci-Guyon E, Babinet C, Braind P, Friedlander G, Poitevin P, Levy B: Impaired flow-induced dilation in mesenteric resistance arteries from mice lacking vimentin. J Clin Invest 1997;100:2909-2914.
31. Schiffers PM, Henrion D, Boulanger CM, Colucci-Guyon E, Langa-Vuves F, vanEssen H, Fazzi GE, Levy BI, De Mey JG: Altered flow-induced arterial remodeling in vimentin-deficient mice. Arterioscler Thromb Vasc Biol 2000;20:611-616.
32. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, Heistad DD: Vascular remodeling. Hypertension 1996;28:505-506.
33. Janiak A, Zemskov EA, Belkin AM: Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190TRhoGAP signaling pathway. Mol Biol Cell 2006;17:1606-1619.
34. Meriane M, Mary S, Comunale F, Vignal E, Fort P, Gauthier-Rouviere C: Cdc42Hs and Rac1 GTPases induce the collapse of the vimentin intermediate filament network. J Biol Chem 2000;275:33046-33052.